Mark J. Ahn is an accomplished executive in the biotech industry.
With a wide range of education from a PhD in Philosophy to a Masters in Business coupled with over 10 years of experience in the life sciences industry, Ahn is a well-rounded business executive in biotechnology and pharmaceuticals.
You can see below his former positions which include executive positions at some of the largest biotech companies and most exciting startups.
President and CEO
Vice Chairman and Board of Directors
Jun 10, 2009 - Current (over 7 years)
Board & Advisor Roles (1)Update
Board of Directors
|Jan 26, 2015||PRNewswire All - Seasoned Biotech Entrepreneur, Mark Ahn, Offers Tech and Business Trends That Will Make a Global Impact|
|Dec 11, 2014||Yahoo Finance - Mark Ahn Shares Five Lessons On Leadership|
|Dec 11, 2014||PRNewswire All - Mark Ahn Shows How Successful Startups Work|
|Sep 26, 2011||Xconomy - RXi Splits Into Two Public Companies After Adding Cancer Vaccine to Pipeline|
|Mar 31, 2011||Xconomy - RXi Buys Apthera, Names New CEO|